Generic drug of the therapeutic class: Otorhinolaryngology
active ingredients: Paracetamol, Pseudoephedrine, Triprolidine
Lab: Johnson & Johnson Sante Bea
Box of 15
Treatment during colds in adults and adolescents over the age of 15:
· Feeling of stuffy nose,
· Clear nasal discharge,
· Headache and / or fever.
Posology ACTIVEED COLD Tablet Box of 15
RESERVED FOR ADULTS AND ADOLESCENTS OVER 15 YEARS OLD.
1 tablet to renew if necessary after 6 hours minimum, not exceeding 3 tablets per day.
The tablet is swallowed as is with a drink (eg water, milk, fruit juice).
In the absence of improvement after 5 days of treatment, it is necessary to take a medical opinion.
In case of severe renal insufficiency (creatinine clearance less than 10 ml / min), the interval between 2 doses will be at least 8 hours. The dose of paracetamol should not exceed 3 g per day.
This medicine is contraindicated in the following situations:
· Hypersensitivity to any of the constituents of the product.
· In children under 15 years old.
· In case of a history of stroke or risk factors that may lead to stroke, due to the sympathomimetic alpha activity of the vasoconstrictor.
· In case of severe or poorly balanced high blood pressure.
· In case of severe coronary insufficiency.
· If there is a risk of glaucoma by closing the angle.
· If there is a risk of urinary retention related to urethroprostatic disorders.
· In case of a history of convulsions.
· In case of hepatocellular insufficiency due to the presence of paracetamol.
· In case of breastfeeding (see section Pregnancy and breastfeeding ).
· In combination with non-selective MAOIs due to the risk of paroxysmal hypertension and potentially fatal hyperthermia (see section 4.5 ).
· In combination with indirect-acting sympathomimetics: vasoconstrictors to decongest the nose, whether administered orally or nasally [phenylephrine (aka neosynephrine), pseudoephedrine, ephedrine] as well as methylphenidate, due to the risk of vasoconstriction and / or hypertensive flare-ups (see section Interactions with other medicinal products and other forms of interaction ).
· In combination with alpha sympathomimetics: vasoconstrictors intended to decongest the nose, whether administered orally or nasally [etilefrine, naphazoline, oxymetazoline, phenylephrine (also known as neosynephrine), synephrine, tetryzoline, tuaminoheptane, tymazoline], as well as midodrine, because of the risk of vasoconstriction and / or hypertensive relapses (see section Interactions with other medicinal products and other forms of interaction ).
The combination of two decongestants is contraindicated, regardless of the route of administration (oral and / or nasal): such an association is useless and dangerous and corresponds to misuse.
This medicine SHOULD NOT BE USED during pregnancy (see section Pregnancy and breastfeeding ).
Actifed Cold Side Effects
Hypersensitivity reactions related to any of the components of this medicine.
Linked to the presence of pseudoephedrine
· Myocardial infarction.
· Glaucoma crisis by closing the angle.
· Dry mouth.
Nervous system disorders
· Hemorrhagic strokes, exceptionally in patients who have used pseudoephedrine hydrochloride-based medicinal products : these strokes have occurred during overdose or misuse in patients with vascular risk factors.
· Ischemic vascular accidents.
· Behavioral disorders.
A fever, an overdose, a drug combination likely to reduce the epileptogenic threshold or to promote an overdose, have often been found and seem to predispose to the occurrence of such effects (see headings Contraindications and Warnings and precautions for use . ).
· Dysuria (especially in cases of urethroprostatic disorders).
· Urinary retention (especially in cases of urethroprostatic disorders).
· Hypertension (hypertensive thrust).
Linked to the presence of paracetamol
· Few cases of hypersensitivity reactions such as anaphylactic shock, angioedema, erythema, urticaria, skin rash have been reported. Their occurrence requires the definitive discontinuation of this drug and related drugs.
· Very exceptional cases of thrombocytopenia, leukopenia and neutropenia have been reported.
Related to the presence triprolidine
The pharmacological characteristics of triprolidine cause undesirable effects of unequal intensity and are dose-related or non-dose related (see section Pharmacokinetic properties ).
· Sedation or drowsiness, more marked at the beginning of treatment,
· orthostatic hypotension,
· Anticholinergic effects such as dryness of the mucous membranes, constipation, accommodation disorders, mydriasis, palpitations, urinary disorders (dysuria, retention),
· Disturbances of balance, vertigo, loss of memory or concentration, more frequent in the elderly,
Motor incoordination, tremors,
· Mental confusion, hallucinations,
· More rarely, effects are of type of excitation: agitation, nervousness, insomnia.
Hypersensitivity reactions (rare)
· Erythema, pruritus, eczema, purpura, urticaria,
· Edema, more rarely angioedema,
· anaphylactic shock.
· Leukopenia, neutropenia,
· Hemolytic anemia.